Centrifugation Conditions in the L-PRP Preparation Affect Soluble Factors Release and Mesenchymal Stem Cell Proliferation in Fibrin Nanofibers
暂无分享,去创建一个
[1] S. Ramtani,et al. The Use of Platelet-Rich Plasma to Promote Cell Recruitment into Low-Molecular-Weight Fucoidan-Functionalized Poly(Ester-Urea-Urethane) Scaffolds for Soft-Tissue Engineering , 2019, Polymers.
[2] L. Rodella,et al. Platelet-Rich Plasma in Treatment of Temporomandibular Joint Dysfunctions: Narrative Review , 2019, International journal of molecular sciences.
[3] Chen Wang,et al. The Differential Effects of Leukocyte-Containing and Pure Platelet-Rich Plasma on Nucleus Pulposus-Derived Mesenchymal Stem Cells: Implications for the Clinical Treatment of Intervertebral Disc Degeneration , 2018, Stem cells international.
[4] I. Cohen,et al. Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma , 2018, PloS one.
[5] R. Skowroński,et al. The application of L-PRP in AIDS patients with crural chronic ulcers: A pilot study. , 2018, Advances in medical sciences.
[6] M. Quirynen,et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane , 2018, Platelets.
[7] Xuedong Zhou,et al. Transforming growth factor-β in stem cells and tissue homeostasis , 2018, Bone Research.
[8] S. Ghanaati,et al. Platelet‐rich fibrin‐based matrices to improve angiogenesis in an in vitro co‐culture model for bone tissue engineering , 2017, Journal of tissue engineering and regenerative medicine.
[9] M. H. Santana,et al. Distribution, recovery and concentration of platelets and leukocytes in L-PRP prepared by centrifugation. , 2018 .
[10] B. A. D. de Melo,et al. Distribution, recovery and concentration of platelets and leukocytes in L-PRP prepared by centrifugation. , 2018, Colloids and surfaces. B, Biointerfaces.
[11] M. H. Santana,et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. , 2017, Regenerative medicine.
[12] S. Ghanaati,et al. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept , 2017, European Journal of Trauma and Emergency Surgery.
[13] Changqing Zhang,et al. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration , 2017, Scientific Reports.
[14] M. Reverte-Vinaixa,et al. Platelet-Rich Plasma Injections for Advanced Knee Osteoarthritis: A Prospective, Randomized, Double-Blinded Clinical Trial , 2017, Orthopaedic journal of sports medicine.
[15] Sridhar,et al. AUTOLOGOUS PLATELET RICH PLASMA (PRP) VERSUS LEUCOCYTE-PLATELET RICH FIBRIN (L-PRF) IN CHRONIC NON-HEALING LEG ULCERS - A RANDOMISED, OPEN LABELLED, COMPARATIVE STUDY , 2016 .
[16] C. Nielsen,et al. The effect of centrifugation speed and time on pre-analytical platelet activation , 2016, Clinical chemistry and laboratory medicine.
[17] M. H. Santana,et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee , 2016, Journal of stem cells & regenerative medicine.
[18] B. Cole,et al. Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis , 2016, The American journal of sports medicine.
[19] W. Parrish,et al. Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leucocyte-rich (type 1a) and leucocyte-poor (type 3b) platelet concentrates , 2016, BMJ Open Sport & Exercise Medicine.
[20] F. Sabatier,et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices , 2016, BMJ Open Sport & Exercise Medicine.
[21] H. Clevers,et al. Reparative inflammation takes charge of tissue regeneration , 2016, Nature.
[22] J. Wang,et al. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries , 2015, Stem Cell Research & Therapy.
[23] S. T. Olalla Saad,et al. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis. , 2015, Cytotherapy.
[24] T. Blunk,et al. Engineering vascularized adipose tissue using the stromal-vascular fraction and fibrin hydrogels. , 2015, Tissue engineering. Part A.
[25] G. Orive,et al. Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties , 2015, PloS one.
[26] M. H. Santana,et al. Performance of PRP Associated with Porous Chitosan as a Composite Scaffold for Regenerative Medicine , 2015, TheScientificWorldJournal.
[27] P. Bauer-Kreisel,et al. Engineering vascularized adipose tissue using the stromal-vascular fraction and fibrin hydrogels. , 2015, Tissue engineering. Part A.
[28] M. H. Santana,et al. Fibrin network architectures in pure platelet-rich plasma as characterized by fiber radius and correlated with clotting time , 2014, Journal of Materials Science: Materials in Medicine.
[29] D. M. Dohan Ehrenfest,et al. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. , 2014, Muscles, ligaments and tendons journal.
[30] Miranda Intrator,et al. A fibrin/hyaluronic acid hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair , 2014, Journal of Biological Engineering.
[31] Ana Amélia Rodrigues,et al. Relevant Aspects of Centrifugation Step in the Preparation of Platelet-Rich Plasma , 2014, ISRN hematology.
[32] N. Maffulli,et al. Platelet-rich plasma for managing pain and inflammation in osteoarthritis , 2013, Nature Reviews Rheumatology.
[33] Sashwati Roy,et al. Neutrophils and Wound Repair: Positive Actions and Negative Reactions. , 2013, Advances in wound care.
[34] Ana Amélia Rodrigues,et al. Prediction and Modulation of Platelet Recovery by Discontinuous Centrifugation of Whole Blood for the Preparation of Pure Platelet-Rich Plasma , 2013, BioResearch open access.
[35] W. Grayson,et al. Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cells. , 2013, Tissue engineering. Part A.
[36] Changqing Zhang,et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. , 2012, Biomaterials.
[37] Ryan P. Russell,et al. Platelet-rich plasma: the PAW classification system. , 2012, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[38] Rachel M. Buchanan,et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. , 2012, Biomaterials.
[39] A. Wiczkowski,et al. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives. , 2012, Current pharmaceutical biotechnology.
[40] D. M. Dohan Ehrenfest,et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). , 2012, Current pharmaceutical biotechnology.
[41] J. Dragoo,et al. Contents and Formulations of Platelet Rich Plasma , 2012 .
[42] Freddie H. Fu,et al. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. , 2012, The Iowa orthopaedic journal.
[43] M. Marcacci,et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.
[44] G. Orive,et al. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.
[45] A. Caplan,et al. PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[46] L. Fortier,et al. Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma , 2011, The American journal of sports medicine.
[47] Johanne Martel-Pelletier,et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.
[48] C A van Blitterswijk,et al. Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model. , 2009, Tissue engineering. Part A.
[49] C. Choong,et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.
[50] S. Jimenez,et al. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. , 2007, Osteoarthritis and cartilage.
[51] A. Nurden,et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. , 2007, Rheumatology.
[52] Michael D. Barnett,et al. Use of Platelet-Rich Plasma and Bone Marrow-Derived Mesenchymal Stem Cells in Foot and Ankle Surgery , 2007 .
[53] Hinrich Wiese,et al. Long-term stable fibrin gels for cartilage engineering. , 2007, Biomaterials.
[54] Erwin G. Van Meir,et al. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.
[55] P. Nurden,et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[56] N. Voitenok,et al. Expression of IL-8 gene in human monocytes and lymphocytes: differential regulation by TNF and IL-1. , 2000, Cytokine.
[57] D. Taub,et al. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. , 1996, The Journal of clinical investigation.
[58] M. Smyth,et al. IL-8 gene expression and production in human peripheral blood lymphocyte subsets. , 1991, Journal of immunology.
[59] D. Spriggs,et al. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. , 1990, Proceedings of the National Academy of Sciences of the United States of America.